Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Canadian cannabis giant Tilray, Inc. (NASDAQ:TLRY) (TSX:TLRY) posted its latest financial earnings report Wednesday, touting a spike in both fourth quarter and full fiscal 2021 revenue and a proclamation from CEO Irwin D. Simon that Tilray is "leading the global cannabis industry with low cost of production, leading brands, a well-developed distribution network, and unique partnerships.

Tilray Shares Up On Reporting First Results Since Merger With Rival Aphria, Reveals $33.6M Profit In Q4

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -37.50% and -0.49%, respectively, for the quarter ended May 2021. Do the numbers hold clues to what lies ahead for the stock?

Tilray, Inc. (TLRY) Reports Q4 Loss, Misses Revenue Estimates

Shares of Canadian cannabis company Tilray Inc. jumped 5.9% in premarket trade Wednesday, after it swung to a profit in its fiscal fourth quarter. Tilray said it had net income of $33.5 million in the quarter to May 31, or 18 cents a share, after a loss of $84.3 million, or 39 cents a share, in the year-earlier period.

Tilray swings to profit in latest quarter, sending stock up 5.9% premarket

While lockdowns in Ontario hit Tilray's revenue during Q4, the Canadian pot producer saw sales increase 27%. Its now-complete Aphria merger is beginning to show positive effects.

TLRY Stock: The News That Has Cannabis Giant Tilray Moving Today

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today reported financial results for the full fiscal year and fourth quarter ended May 31, 2021. Results for the full year and fourth quarter include legacy-Aphria's fiscal 2021 financial results and four weeks of Tilray. All financial information in this press release is reported in U.S. dollars, unless oth

Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results

SNDL Inc.

OrganiGram Holdings Inc.

Even after a month of declines, these stocks are much higher year to date.

Why Tilray, Sundial Growers, and Other Cannabis Stocks Dropped Today

Village Farms International

Why Are These Marijuana Stocks Getting More Hype? The post Here's Why These Marijuana Stocks Are Good For Your Portfolio appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Here's Why These Marijuana Stocks Are Good For Your Portfolio

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) is scheduled to report its quarterly earnings on July 28th, before the market opens. Year-to-date, the stock is up 35.12%.

Cantor Fitzgerald Lowers Price Target On Tilray Cannabis Co Ahead Of Earnings Report, Sees Several Catalysts Including U.S. Plans

The world's leading brand in hemp foods, Manitoba Harvest will lend its expertise in innovation, product development, and formulation to a consortium of industry leaders through Protein Industries Canada. WINNIPEG, MB, July 27, 2021 /PRNewswire/ - Manitoba Harvest, the global leader in hemp food, is partnering with a consortium of industry leaders through Protein Industries Canada to develop new hemp and pea varieties with increased protein content, differential starch content, and improved texture.

Manitoba Harvest Announces New Research Partnership to Drive Innovation in Hemp and Pea Protein

Boeing

McDonald's

Pfizer

The five largest U.S. traded companies report June-quarter earnings this week, beginning Monday evening with Tesla.

Earnings Previews: Boeing, McDonald's, Pfizer, Tilray

Clover Leaf Capital Corp

Clever Leaves Holdings Inc

GrowGeneration Corp

High Tide

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

6 Cannabis Stocks Heating Up This Summer

Canopy Growth

Cronos Group

Canadian Marijuana Stocks To Watch Right Now The post Best Canadian Marijuana Stocks To Buy? 4 Top Pot Stocks To Watch Before Earnings appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks To Buy? 4 Top Pot Stocks To Watch Before Earnings

Better Marijuana Stock: Sundial Growers vs. Tilray

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fiscal fourth-quarter results.

Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?

Greenlane Holdings

HEXO Corp

Marijuana penny stocks that can deliver multi-fold returns. Penny stocks with a promising business outlook in a sector with long-term tailwinds.

7 Marijuana Penny Stocks To Buy for High Returns

Aurora Cannabis

Are marijuana investors paranoid about "cannabis-induced psychosis"?

Why Aurora Cannabis, Tilray, Hexo, and Sundial Investors Are Panicking Today

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

These marijuana stocks are set for incredible gains in post-legalization America. Consider these seven pot plays as the industry gears up.

7 Marijuana Stocks to Own Ahead of U.S. Federal Legalization

Canadian Marijuana Stocks To Watch Before August The post While Top Cannabis Stocks Are Down Are Pot Stocks A Good Investment? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

While Top Cannabis Stocks Are Down Are Pot Stocks A Good Investment?

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) confirmed Wednesday that another independent proxy advisory firm is recommending that shareholders back all the company's proposals at a special meeting scheduled for July 29. This time, the proxy advisory services company Glass Lewis also advised shareholders to vote in favor of the company's dilution as well as other proposals.

Tilray Urging Shareholders To Support Dilution, Proxy Advisory Firm Joins The Plea Ahead Of Upcoming Shareholders Meeting

Flower One Hldgs (OTC:FLOOF) shares closed up 17.57% at $0.15 Empower Clinics (OTC:EPWCF) shares closed up 11.91% at $0.44

Bullish Trend Continues In Cannabis Market: Tilray, Canopy Growth & GrowGen Among Top Cannabis Movers For July 21, 2021

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that Glass Lewis, a leading independent provider of proxy research and vote recommendations to the investment community, has joined the other major independent proxy research firm, ISS, in recommending that Tilray shareholders vote “FOR” the Company's proposals at Tilray's Special Meeting of Stock

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Tilray Shareholders Vote “FOR” All Proposals at Tilray's Upcoming Special Meeting

Cannabis stocks closed down nearly 9% this week, according to the Alternative Harvest ETF. The market clearly viewed the Schumer/Booker proposal as little more than political posturing having virtually no chance of being passed.

Cannabis Industry Chart Of The Week: Has The Market Rationally Priced The Prospects For Federal Legalization?

Empower Clinics (OTC:EPWCF) shares closed up 18.43% at $0.39 Origin Agritech (NASDAQ:SEED) shares closed up 17.82% at $11.04

Bullish Sentiment Pumps Up Cannabis Stocks: Tilray, Sundial, Aurora & GrowGen Among Top Cannabis Movers For July 20, 2021

Innovative Industrial Properties

Top 10 Marijuana Companies Earnings Calendar The post Top 10 Marijuana Stocks To Watch During Earnings Season appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top 10 Marijuana Stocks To Watch During Earnings Season

Wait! Hold up a sec! President Biden opposes marijuana legalization?

Why Aurora Cannabis, Tilray, and Charlotte's Web Stocks Fell Today

News for Tilray Brands Stock (TLRY)